GKOS
Price
$184.89
Change
-$0.00 (-0.00%)
Updated
Aug 21 closing price
Capitalization
10.91B
73 days until earnings call
Intraday BUY SELL Signals
MLSS
Price
$0.48
Change
+$0.01 (+2.13%)
Updated
Aug 21 closing price
Capitalization
42.67M
81 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GKOS vs MLSS

GKOS vs MLSS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GKOS vs. MLSS commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Hold and MLSS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (GKOS: $184.89 vs. MLSS: $0.48)
Brand notoriety: GKOS and MLSS are both not notable
GKOS represents the Medical/Nursing Services, while MLSS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GKOS: 51% vs. MLSS: 49%
Market capitalization -- GKOS: $10.91B vs. MLSS: $42.67M
GKOS [@Medical/Nursing Services] is valued at $10.91B. MLSS’s [@Pharmaceuticals: Other] market capitalization is $42.67M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $201.83B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $133.83B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $6.08B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 1 FA rating(s) are green whileMLSS’s FA Score has 0 green FA rating(s).

  • GKOS’s FA Score: 1 green, 4 red.
  • MLSS’s FA Score: 0 green, 5 red.
According to our system of comparison, GKOS is a better buy in the long-term than MLSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 3 TA indicator(s) are bullish while MLSS’s TA Score has 3 bullish TA indicator(s).

  • GKOS’s TA Score: 3 bullish, 5 bearish.
  • MLSS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both GKOS and MLSS are a bad buy in the short-term.

Price Growth

GKOS (@Medical/Nursing Services) experienced а +0.20% price change this week, while MLSS (@Pharmaceuticals: Other) price change was -2.89% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.94%. For the same industry, the average monthly price growth was +6.51%, and the average quarterly price growth was -7.37%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.08%. For the same industry, the average monthly price growth was +10.50%, and the average quarterly price growth was +5.94%.

Reported Earning Dates

GKOS is expected to report earnings on Nov 04, 2026.

MLSS is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Medical/Nursing Services (-0.94% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.08% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($10.9B) has a higher market cap than MLSS($42.7M). MLSS YTD gains are higher at: 76.117 vs. GKOS (63.750). MLSS has higher annual earnings (EBITDA): -4.34M vs. GKOS (-141.49M). GKOS has more cash in the bank: 286M vs. MLSS (1.19M). MLSS has less debt than GKOS: MLSS (985K) vs GKOS (103M). GKOS has higher revenues than MLSS: GKOS (613M) vs MLSS (8.9M).
GKOSMLSSGKOS / MLSS
Capitalization10.9B42.7M25,527%
EBITDA-141.49M-4.34M3,261%
Gain YTD63.75076.11784%
P/E RatioN/AN/A-
Revenue613M8.9M6,885%
Total Cash286M1.19M23,953%
Total Debt103M985K10,457%
FUNDAMENTALS RATINGS
GKOS vs MLSS: Fundamental Ratings
GKOS
MLSS
OUTLOOK RATING
1..100
4442
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
31100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
3639
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
5042

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GKOS's Valuation (95) in the Medical Specialties industry is in the same range as MLSS (97). This means that GKOS’s stock grew similarly to MLSS’s over the last 12 months.

GKOS's Profit vs Risk Rating (31) in the Medical Specialties industry is significantly better than the same rating for MLSS (100). This means that GKOS’s stock grew significantly faster than MLSS’s over the last 12 months.

GKOS's SMR Rating (97) in the Medical Specialties industry is in the same range as MLSS (99). This means that GKOS’s stock grew similarly to MLSS’s over the last 12 months.

GKOS's Price Growth Rating (36) in the Medical Specialties industry is in the same range as MLSS (39). This means that GKOS’s stock grew similarly to MLSS’s over the last 12 months.

GKOS's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for MLSS (100). This means that GKOS’s stock grew somewhat faster than MLSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSMLSS
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 27 days ago
68%
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GKOS
Daily Signal:
Gain/Loss:
MLSS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QCLGX29.550.19
+0.65%
Federated Hermes MDT Large Cap Growth C
SCVNX43.760.22
+0.51%
Allspring Small Company Value Inst
CMRAX10.65N/A
N/A
Calamos Merger Arbitrage A
IJMIX12.41N/A
N/A
VY® JPMorgan Mid Cap Value I
VARCX10.66N/A
N/A
First Trust Merger Arbitrage Cl C

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
N/A
ISRG - GKOS
51%
Loosely correlated
+1.16%
NTRA - GKOS
48%
Loosely correlated
+2.21%
RDNT - GKOS
48%
Loosely correlated
-0.30%
TWST - GKOS
46%
Loosely correlated
+6.79%
ALGN - GKOS
43%
Loosely correlated
+2.27%
More

MLSS and

Correlation & Price change

A.I.dvisor tells us that MLSS and ANGO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and ANGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+2.23%
ANGO - MLSS
29%
Poorly correlated
-0.44%
ESTA - MLSS
26%
Poorly correlated
+1.61%
QDEL - MLSS
25%
Poorly correlated
-0.74%
GKOS - MLSS
25%
Poorly correlated
N/A
VTAK - MLSS
25%
Poorly correlated
-0.52%
More